Literature DB >> 11326227

Computer-enhanced "robotic" cardiac surgery: experience in 148 patients.

F W Mohr1, V Falk, A Diegeler, T Walther, J F Gummert, J Bucerius, S Jacobs, R Autschbach.   

Abstract

OBJECTIVE: A computer-enhanced instrumentation system was used in 148 patients to minimize access in cardiac surgical procedures.
METHODS: The da Vinci telemanipulation system (Intuitive Surgical, Mountain View, Calif) provides a high-resolution 3-dimensional videoscopic image and allows remote, tremor-free, and scaled control of endoscopic surgical instruments with 6 degrees of freedom. By April 2000, the system had been used in 131 patients for coronary artery bypass grafting and 17 patients for mitral valve repair. In the coronary bypass group, the system was used in one of three ways: (1) to take down the internal thoracic artery followed by a minimally invasive direct coronary bypass procedure (n = 81); (2) to perform the anastomosis between the internal thoracic artery and the left anterior descending coronary artery in standard-sternotomy coronary bypass (n = 15); or (3) for total endoscopic coronary artery bypass grafting to anastomose the left internal thoracic artery to the left anterior descending on the arrested heart (n = 27) or the beating heart (n = 8). In 17 patients with nonischemic mitral valve insufficiency the mitral valve was repaired. Closed-chest cardiopulmonary bypass with cardioplegic arrest (Port-Access technique; Heartport, Inc, Redwood City, Calif) was used for arrested-heart total endoscopic coronary bypass and mitral valve repair.
RESULTS: The da Vinci system allows for precise tissue handling and enables the endoscopic performance of cardiac surgical tasks that require a high degree of dexterity (coronary anastomosis, mitral valve repair). No technical mishaps have occurred. The internal thoracic artery was successfully taken down in 79 of 81 patients in the group undergoing minimally invasive coronary bypass and, after a steep learning curve, is currently performed in less than 40 minutes. The postoperative patency rate is 96.3%. Total endoscopic coronary bypass was completed in 22 of 27 cases with 95.4% patency as demonstrated by angiography at 3 months' follow-up. Closed-chest endoscopic beating-heart bypass grafting was successfully performed in 2 out of 8 patients with the use of a new endoscopic stabilizer. In the group having mitral valve repair, primary endoscopic computer-enhanced repair was successfully completed in 14 of 17 patients; three others had to be changed to a standard endoscopic technique, including 1 who required valve replacement. At 3 months' follow-up, 1 additional patient underwent early reoperation for recurrent mitral insufficiency. Overall early and late mortality in this cohort of 148 patients was 2.0% and was not related to the use of the system.
CONCLUSION: In conclusion, computer-enhanced endoscopic cardiac surgery can be performed safely in selected patients. Internal thoracic artery takedown is now routinely performed with good results. Total endoscopic coronary bypass is feasible on the arrested heart but does not offer a major benefit over the minimally invasive direct approach because cardiopulmonary bypass is still required. The early clinical experience with closed-chest beating-heart bypass grafting outlines the limitations of this approach despite some procedural success.

Entities:  

Mesh:

Year:  2001        PMID: 11326227     DOI: 10.1067/mtc.2001.112625

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  36 in total

1.  Surgical Approaches to Coronary Artery Disease.

Authors:  Farzan Filsoufi; David H. Adams
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-02

2.  Evolving techniques for mitral valve reconstruction.

Authors:  Aubrey C Galloway; Eugene A Grossi; Costas S Bizekis; Greg Ribakove; Patricia Ursomanno; Julie Delianides; F Gregory Baumann; Frank C Spencer; Stephen B Colvin
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

Review 3.  Robotic surgery: a current perspective.

Authors:  Anthony R Lanfranco; Andres E Castellanos; Jaydev P Desai; William C Meyers
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

4.  First report on sequential totally endoscopic thymomectomy and adrenalectomy using computer-enhanced telemanipulation.

Authors:  M F Khan; J Binder; S Dogan; W Bentas; T Aybek; G Wimmer-Greinecker
Journal:  Surg Endosc       Date:  2003-06-19       Impact factor: 4.584

5.  Application of haptic feedback to robotic surgery.

Authors:  Brian T Bethea; Allison M Okamura; Masaya Kitagawa; Torin P Fitton; Stephen M Cattaneo; Vincent L Gott; William A Baumgartner; David D Yuh
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2004-06       Impact factor: 1.878

6.  High-sensitive fluorescence endoscope using electrocardiograph-synchronized multiple exposure.

Authors:  Takehiro Ando; Kazuhiro Taniguchi; Hongho Kim; Sanghyun Joung; Etsuko Kobayashi; Hongen Liao; Shunei Kyo; Ichiro Sakuma
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-05-16       Impact factor: 2.924

7.  Preliminary design of an actuated imaging probe for generation of additional visual cues in a robotic surgery.

Authors:  Carlos A Velasquez; Nikhil V Navkar; Amer Alsaied; Shidin Balakrishnan; Julien Abinahed; Abdulla A Al-Ansari; W Jong Yoon
Journal:  Surg Endosc       Date:  2015-12-17       Impact factor: 4.584

Review 8.  Training and outcome monitoring in robotic urologic surgery.

Authors:  Daniel Liberman; Quoc-Dien Trinh; Claudio Jeldres; Luc Valiquette; Kevin C Zorn
Journal:  Nat Rev Urol       Date:  2011-11-08       Impact factor: 14.432

9.  Clinical characteristics of remote Zeus robot-assisted laparoscopic cholecystectomy: a report of 40 cases.

Authors:  Han-Xin Zhou; Yue-Hua Guo; Xiao-Fang Yu; Shi-Yun Bao; Jia-Lin Liu; Yue Zhang; Yong-Gong Ren; Qun Zheng
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

10.  Methods for haptic feedback in teleoperated robot-assisted surgery.

Authors:  A M Okamura
Journal:  Ind Rob       Date:  2004-12       Impact factor: 1.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.